Ophthalmological Microscopes
Welcome to Ophthalmological Microscopes.Intelerad Launches InteleOne Solution at RSNA 2008
Intelerad Launches InteleOne Solution at RSNA 2008
 |
 |
 |
Click Here to read the entire article...
Other Articles:
| • | Tesetaxel, Leading Oral Taxane In Clinical Development, Receives FDA Designation As An Orphan Drug For Treatment Of Patients With Advanced Melanoma |
| Genta Incorporated (OTCBB: GNTA) announced today that the Company has received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the Company's oral taxane in clinical development, has been granted designation as an "Orphan Drug" for treatment of patients with advanced melanoma. Orphan drug status provides for a period of marketing exclusivity, certain tax benefits, and an exemption from certain fees upon submission of a New Drug Application. | |
| Click Here to read the entire article... |
|
| • | Bronchus Cardiacus Accessorius Dexter |
| The diagnosis of bronchus cardiacus accessorius dexter (BCAD) has occurred in 25 cases during the bronchoscopic investigations of 30,000 adult patients of the authors. In most of the cases, this bronchial anomaly has been revealed as an accessory phenomenon, nevertheless, in one of the patients, it was the source of a considerable hemorrhage. In another case reported here in detail, it occurred together with multiple developmental anomalies, such as tracheobronchomegaly, mitral valve prolapse, pectus excavatum, hypoplasy of sinus frontalis on the right side, inguinal hernia on the left side and hyperlipidemia type IV. Family analysis did not confirm the presence of any chromosomal disorders or accumulation of similar developmental anomalies. The forms and frequency of associations of the anomalies are surveyed on the basis of literary data. The recognition of BCAD is of diagnostic importance, since it may explain the persistence of some bronchopulmonary symptoms; furthermore, the exploration of the associated abnormal vascular branches may be very useful in case of an eventual thoracic surgical intervention. | |
| Click Here to read the entire article... |
|
| • | "Competitive Advantage in a Changing World": Chinese Business Leaders Visit IESE |
 On Wednesday, Nov. 20, a delegation of Chinese business executives were on IESE's campus in Barcelona to participate in the conference "Competitive Advantage in A Changing World." |
|
| Click Here to read the entire article... |
|
| • | |
| Click Here to read the entire article... |
|
| • | [Anatomy and Pathology] Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma |
|
Activating mutations in GNAQ occur in about half of uveal melanomas and are not associated with any features of late tumor progression, consistent with an early or initiating event. |
|
| Click Here to read the entire article... |
|
| • | [Knee] Midterm survival of a contemporary modular total knee replacement: A MULTICENTRE STUDY OF 1970 KNEES |
|
This retrospective study evaluated the midterm clinical and radiographic outcomes of a second-generation total knee replacement system. In a multicentre consecutive series of 1512 patients, 1970 knees were treated with the PFC Sigma knee system (Depuy, Warsaw, Indiana). The patients were reviewed for functional outcome, and underwent independent radiographic evaluation at a mean follow-up of 7.3 years (5 to 10). A total of 40 knees (2%) required revision, 17 (0.9%) for infection. The incidence of osteolysis was 2.2%. The ten-year survival with revision for any cause other than infection as the endpoint was 97.2% (95% CI 95.4 to 99.1). The PFC Sigma knee system appears to provide excellent results in the medium term. |
|
| Click Here to read the entire article... |
|
By editors@medicalnewstoday.com (MNT Editors) - © 2008, Hindawi Publishing Corporation. All rights reserved. - version: v1.5 build A